News | January 31, 2026
Astec LifeSciences posts robust Q3 growth
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
The base Gland business posted ?11,790 million in revenue, up 16% YoY
Excluding Vacaville-related business, organic CER sales growth reached the low-teens with improved CORE EBITDA margins, in line with Lonza’s CDMO Organic Growth Model
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
Subscribe To Our Newsletter & Stay Updated
